Clayton Lisa M, Azadi Bahar, Eldred Claire, Wilson Galia, Robinson Robert, Sisodiya Sanjay M
UCL Queen Square Institute of Neurology (LMC, SMS), London; Chalfont Centre for Epilepsy (LMC, SMS), Bucks; Great Ormond Street Hospital (BA, RR), London; and Dravet Syndrome UK (CE, GW), Registered Charity Number 1128289, Member of Dravet Syndrome European Federation, Chesterfield, United Kingdom.
Neurol Clin Pract. 2024 Jun;14(3):e200288. doi: 10.1212/CPJ.0000000000200288. Epub 2024 Apr 23.
Dravet syndrome (DS) is one of the most common monogenic epilepsies. Alongside the core seizure and developmental phenotypes, problems with appetite, swallowing, and weight loss are frequently reported, necessitating gastrostomy in some. We explored the burden of feeding difficulties and need for gastrostomy across 3 DS populations in the United Kingdom. We document caregiver opinion and postgastrostomy outcomes, and provide guidance regarding feeding issues and gastrostomy in DS.
A retrospective, observational study was conducted; data were collected from medical records of 124 individuals with DS attending clinics at the National Hospital for Neurology and Neurosurgery, and Great Ormond Street Hospital, and from 65 DS caregiver responses to a UK-wide survey.
In total, 64 of 124 (52%) had at least 1 feeding difficulty; 21 of 124 (17%) had a gastrostomy, and gastrostomy was being considered in 5%; the most common reasons for gastrostomy were poor appetite (81%) and weight loss/failure to gain weight (71%). Median age at gastrostomy was 17 years (range 2.5-59). Multivariate analyses identified several factors that in combination contributed to risk of feeding difficulties and gastrostomy, including treatment with several antiseizure medications (ASMs), of which stiripentol made a unique contribution to risk of gastrostomy ( = 0.048, odds ratio 3.20, 95% CI 1.01-10.16). Preinsertion, 88% of caregivers were worried about the gastrostomy, with concerns across a range of issues. Postgastrostomy, 88% of caregivers were happy that their child had the gastrostomy, and >90% agreed that the gastrostomy ensured medication compliance, that their child's overall health was better, and that quality of life improved.
Feeding difficulties are common in DS, and 17% require a gastrostomy to address these. Risk factors for feeding difficulties in DS are unknown, but ASMs may play a role. There is a high level of caregiver concern regarding gastrostomy preprocedure; however, postgastrostomy caregiver opinion is positive. Feeding difficulties should be proactively sought during review of people with DS, and the potential need for gastrostomy should be discussed.
德雷维特综合征(DS)是最常见的单基因癫痫之一。除了核心的癫痫发作和发育表型外,食欲、吞咽和体重减轻问题也经常被报道,部分患者需要进行胃造口术。我们探讨了英国3个DS患者群体中喂养困难的负担以及胃造口术的需求。我们记录了照料者的意见和胃造口术后的结果,并提供了关于DS喂养问题和胃造口术的指导。
进行了一项回顾性观察研究;数据收集自124名在国家神经病学和神经外科医院以及大奥蒙德街医院就诊的DS患者的病历,以及65名DS照料者对全英范围调查的回复。
124名患者中共有64名(52%)至少存在1种喂养困难;124名中有21名(17%)进行了胃造口术,5%的患者正在考虑进行胃造口术;胃造口术最常见的原因是食欲不佳(81%)和体重减轻/体重未增加(71%)。胃造口术的中位年龄为17岁(范围2.5 - 59岁)。多变量分析确定了几个共同导致喂养困难和胃造口术风险的因素,包括使用多种抗癫痫药物(ASMs)治疗,其中司替戊醇对胃造口术风险有独特影响(P = 0.048,比值比3.20,95%置信区间1.01 - 10.16)。插入胃造口管前,88%的照料者担心胃造口术,涉及一系列问题。胃造口术后,88%的照料者对孩子接受胃造口术感到满意,超过90%的人同意胃造口术确保了药物依从性,孩子的整体健康状况更好,生活质量得到改善。
喂养困难在DS中很常见,并导致17%的患者需要胃造口术来解决这些问题。DS喂养困难的风险因素尚不清楚,但抗癫痫药物可能起了作用。照料者在胃造口术前高度关注;然而,胃造口术后照料者的意见是积极的。在对DS患者进行复查时应主动查找喂养困难情况,并应讨论胃造口术的潜在需求。